Business
Novo obesity data positive for Eli Lilly and Amgen, says UBS - Yahoo Finance
UBS analyst Trung Huynh says Novo Nordisk’s (NVO) CagriSema Phase 3 topline obesity data “underwhelmed,” a positive read-through to Eli Lilly (LLY) and Amgen...
By: Yahoo Entertainment
- Dec 23 2024
- 0
- 0 Views
https://www.tipranks.com/news/the-fly/novo-obesity-data-positive-for-eli-lilly-and-amgen-says-ubs
UBS analyst Trung Huynh says Novo Nordisks (NVO) CagriSema Phase 3 topline obesity data underwhelmed… [+834 chars]